Lupus vulgaris, isoniazid, and cancer. The frequency of cancer deaths in 245 isoniazid-treated lupus vulgaris patients with an average observation period of 12 years.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D003110:Colonic Neoplasms / Q000139:chemically induced; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects*; D007822:Laryngeal Neoplasms / Q000139:chemically induced; D008177:Lupus Vulgaris / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced* / Q000401:mortality; D010051:Ovarian Neoplasms / Q000139:chemically induced; D010190:Pancreatic Neoplasms / Q000139:chemically induced; D012004:Rectal Neoplasms / Q000139:chemically induced; D012737:Sex Factors; D013997:Time Factors